Otsuka (OTSKF) Stock Price, News & Analysis

Company Overview

Otsuka Holdings Co., Ltd. is a Japan-based healthcare company that operates through a global group of businesses focused primarily on pharmaceuticals and nutraceuticals. Its pharmaceutical operations develop and commercialize prescription medicines in areas including psychiatry, neurology, oncology, cardiovascular disease and several other therapeutic fields.

Through Otsuka Pharmaceutical and related subsidiaries, the company also offers consumer health and nutrition products, functional beverages, supplements and medical foods. Its product portfolio includes prescription treatments such as Abilify and Rexulti, as well as nutrition-oriented brands including Pocari Sweat and CalorieMate in selected markets.

Otsuka traces its origins to a pharmaceutical business established in Japan in 1921 and has expanded into an international healthcare group serving markets across Japan, North America, Europe and other regions. The company combines pharmaceutical research with nutrition and consumer-health activities, reflecting its stated focus on addressing health needs from both medical and everyday wellness perspectives.

Key Stats

• Today's Range: $74.00 to $74.00
• 50-Day Range: $66.00 to $77.53
• 52-Week Range: $54.26 to $79.00
• Volume: 20 shs
• Average Volume: 308 shs
• Market Capitalization: N/A
• P/E Ratio: 0.25
• Dividend Yield: 75.38%
• Price Target: N/A
• Consensus Rating: N/A

Otsuka Stock Analysis - MarketRank™

Otsuka scored higher than 11% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: N/A
• Analyst Rating: N/A

Consensus Rating

There is not enough analysis data for Otsuka.

Earnings and Valuation

• Score: 1.3 / 5
• Proj. Earnings Growth: N/A

Price to Earnings Ratio vs. the Market

The P/E ratio of Otsuka is 0.25, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 38.82.

Price to Earnings Ratio vs. Sector

The P/E ratio of Otsuka is 0.25, which means that it is trading at a less expensive P/E ratio than the Healthcare sector average P/E ratio of about 275.05.

Short Interest

• Score: 0.0 / 5
• Short Interest Level: Bearish

Percentage of Shares Shorted

Short Interest Ratio / Days to Cover

Otsuka has a short interest ratio ("days to cover") of 999.99, which indicates bearish sentiment.

Change versus previous month

Short interest in Otsuka has recently increased by 4.82%, indicating that investor sentiment is decreasing.

Dividend

• Score: 1.7 / 5
• Dividend Strength: Weak

Dividend Yield

Otsuka pays a meaningful dividend of 3.45%, higher than the bottom 25% of all stocks that pay dividends.

Dividend Growth

Otsuka does not have a long track record of dividend growth.

Dividend Coverage

The dividend payout ratio of Otsuka is 18.48%. This payout ratio is at a healthy, sustainable level, below 75%.

News and Social Media

• Score: 2.1 / 5
• News Sentiment: 0.37

News Sentiment

Otsuka has a news sentiment score of 0.37. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.75 average news sentiment score of Healthcare companies.

News Coverage This Week

MarketBeat has tracked 7 news articles for Otsuka this week, compared to 1 article on an average week.

Company Ownership

• Score: 0.1 / 5
• Insider Trading: N/A

Insider Buying vs. Insider Selling

In the past three months, Otsuka insiders have not sold or bought any company stock.

Percentage Held by Institutions

12.20% of the stock of Otsuka is held by institutions.

Company Calendar

• Today: 9/28/2026
• Next Earnings (Estimated): 10/30/2026

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Healthcare
• Industry: Pharmaceuticals
• Sub-Industry: Pharmaceuticals
• Current Symbol: OTCMKTS:OTSKF
• CIK: 1544613
• Web: www.otsuka.com
• Phone: (136) 717-1410
• Fax: N/A
• Employees: 34,388
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: 0.25
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: N/A
• Free Float: N/A
• Market Cap: N/A
• Optionable: Not Optionable
• Beta: N/A